On October 12, 10x Genomics, Inc. fell 5.17% in regular trading, trading at $76.75/share with Turnover of $51.63 million. The decline came amid broad-based pressure across the life science tools and services sector, with peer stocks also trading lower.
Within the Life Sciences Tools & Services industry, the overall sector trend was negative. Among individual stocks, Thermo Fisher Scientific fell 0.31%, Danaher rose 0.01%, Waters fell 1.24%, Illumina fell 2.91%, and Tempus AI fell 3.17%.
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products across North America, Europe, the Middle East, Africa, China, and the Asia Pacific.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)